Chronic inflammation and hemodialysis reduce immune competence of peripheral blood leukocytes in end-stage renal failure patients

被引:22
|
作者
Knerr, K
Füth, R
Hemsen, P
Mohné, W
Heinig, A
Kleophas, W
Scherbaum, WA
Martin, S
机构
[1] Univ Dusseldorf, Leibniz Inst, German Diabet Ctr, German Diabet Clin, D-40225 Dusseldorf, Germany
[2] Kuratorium Heimdialyse, Evangel Krankenhaus, Dusseldorf, Germany
[3] Diabet Schwerpunkttpraxis, Dusseldorf, Germany
关键词
cytokines; immune reactivity; leukocytes; mRNA; renal failure;
D O I
10.1016/j.cyto.2004.12.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Immunoincompetence is a profound problem in end-stage renal failure patients undergoing hemodialysis, and chronic inflammation with altered serum levels of inflammation markers has been reported. Gene expression patterns have had little relevance for leukocyte research so far because of limitations in transcript levels and stability. Using a new stimulation system we induced the expression of immune-relevant transcripts in whole blood preparations ex vivo and stabilized transcript levels by preventing RNA degradation and uncontrolled gene induction. Using quantitative real-time PCR we could show that basal TGF-beta mRNA expression is about 2-fold decreased in end-stage renal failure patients, while expression of TNF-alpha becomes 2-fold increased, further doubling during hemodialysis. By short term stimulation with phytohemagglutinin (PHA) for 2 h we tested for the immune competence of peripheral blood leukocytes and demonstrated that hemodialysis decreases TNF-alpha-mediated immune responsiveness more than 3-fold. This study shows by induction and stabilization of immune-relevant transcripts that chronic inflammation and hemodialysis are crucial factors for disturbed immune competence of end-stage renal failure patients. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:132 / 138
页数:7
相关论文
共 50 条
  • [31] Mineralocorticoid Receptor Antagonists in Patients With End-Stage Renal Disease on Chronic Hemodialysis
    Pitt, Bertram
    Rossignol, Patrick
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (06) : 537 - 538
  • [32] Chronic inflammation in end-stage renal disease and dialysis
    Cobo, Gabriela
    Lindholm, Bengt
    Stenvinkel, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33 : 35 - 40
  • [33] Effect of hemodialysis on whole blood viscosity for end-stage kidney failure patients
    Cho, Y. I.
    Vaisman, S.
    Kensey, K.
    BIORHEOLOGY, 2008, 45 (1-2) : 80 - 81
  • [34] REGULAR SHORT HEMODIALYSIS IN END-STAGE RENAL-FAILURE
    MARTIN, AM
    ODURODOMINAH, A
    GIBBINS, JK
    DEVAPAL, D
    MITCHELL, DC
    BRITISH MEDICAL JOURNAL, 1975, 3 (5986): : 758 - 759
  • [35] Are There Alternatives to Hemodialysis for the Elderly Patient With End-Stage Renal Failure?
    Thorsteinsdottir, Bjorg
    Swetz, Keith M.
    Feely, Molly A.
    Mueller, Paul S.
    Williams, Amy W.
    MAYO CLINIC PROCEEDINGS, 2012, 87 (06) : 514 - 516
  • [36] VESICOURETERAL REFLUX IN PATIENTS IN END-STAGE CHRONIC RENAL-FAILURE
    MOSCONI, CEV
    IANHEZ, LE
    BORRELLI, M
    SABBAGA, E
    FREIRE, JGC
    UROLOGIA INTERNATIONALIS, 1975, 30 (05) : 357 - 361
  • [37] BLOOD GLUCOSE METER PERFORMANCE IN PATIENTS WITH END-STAGE RENAL FAILURE
    Pfuetzner, A.
    Westphalen, S.
    Pfuetzner, A. H.
    Demircik, F.
    Ramljak, S.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2015, 17 : A152 - A152
  • [38] Depression in end-stage renal disease hemodialysis patients
    Cukor, Daniel
    Peterson, Rolf A.
    Cohen, Scott D.
    Kimmel, Paul L.
    NATURE CLINICAL PRACTICE NEPHROLOGY, 2006, 2 (12): : 678 - 687
  • [39] Depression in end-stage renal disease hemodialysis patients
    Daniel Cukor
    Rolf A Peterson
    Scott D Cohen
    Paul L Kimmel
    Nature Clinical Practice Nephrology, 2006, 2 : 678 - 687
  • [40] Effects of hemodialysis on iodine-131 biokinetics in thyroid carcinoma patients with end-stage chronic renal failure
    Yeyin, Nami
    Cavdar, Iffet
    Uslu, Lebriz
    Abuqbeitah, Mohammad
    Demir, Mustafa
    NUCLEAR MEDICINE COMMUNICATIONS, 2016, 37 (03) : 283 - 287